Synapse Medicine
Series BSynapse Medicine raised €25M in a Series B round in Mar 2022. The company is based in Bordeaux, France. Investors in the round: BNP Paribas Development, Fleur Pellerin investment fund, Korelya Capital and 2 others. Data as of 4 Nov 2026.
Amount raised
€25M
€25,000,000
Native amount
25,000,000 EUR
Stage
Series B
series b
Investors
5
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €25M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
5 namedDate
Mar 2022
Round type
series b
Amount (EUR)
€25M
Other rounds
same companyRelated news
- Medication intelligence platform Synapse Medicine raises €25 milliontech.eu · 2022-03